Literature DB >> 33660092

Observation of fundus and optical coherence tomography angiography manifestations in carotid cavernous fistula patients.

Xuqian Wang1, Xiaobo Zhang2, Linyang Gan1, Yuhan Wang1, Jin Ma3, Yong Zhong4.   

Abstract

PURPOSE: This study aimed to investigate fundus and optical coherence tomography angiography (angio-OCT) manifestations in carotid cavernous fistula (CCF) patients.
METHODS: Nine eyes of 7 CCF patients diagnosed with digital subtraction angiography (DSA) were included in this study. Best-corrected visual acuity (BCVA), intraocular pressure (IOP), slit lamp, fundus, spectral-domain optical coherence tomography (SD-OCT), and optical coherence tomography angiography (angio-OCT) examination in the CCF patients and 10 normal controls were conducted. Subfoveal choroidal thickness (SFCT) and macular vascular density (VD) were measured and compared with the control group. SFCT and VD were also compared before and after embolization therapy.
RESULTS: Two male and 5 female CCF patients were included. The average age was 59.7 ±10.0 (years). Embolization therapy was conducted in 3 patients. Fundus manifestations included disc oedema and exudation, retinal venular dilation, and retinal haemorrhage. B-scan OCT examination revealed retinal and choroidal undulations, retinal-choroidal thickness, retinal cystoid oedema, and subretinal fluid. The SFCT of the affected eyes was thicker than that of the control group (412.3 ± 123.7 μm vs. 272.9 ± 62.9 μm; P = 0.006). Macular superficial capillary plexus (SCP) VD in affected eyes was lower than that in the control eyes (50.1 ±2.3 % vs. 52.7 ± 1.7 % ; P = 0.014). The SFCT was reduced, and the vessel density in the SCP was increased after embolization therapy.
CONCLUSION: We demonstrated decreased VD in CCF patients with specific fundus and OCT manifestations. The pathological changes were immediately reduced after embolization therapy. This preliminary observation provides a supplemental method for the diagnosis and pathophysiological examination of CCF patients.

Entities:  

Keywords:  Angio-OCT; CCF; Carotid cavernous fistula; Optical coherence tomography angiography; Vessel density

Year:  2021        PMID: 33660092     DOI: 10.1007/s00417-021-05117-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  7 in total

1.  [Low flow cavernous sinus fistula. Treatment by highly selective embolization].

Authors:  M G Lanzas; E Maraví; J Masó; J Hernández-Abenza
Journal:  Rev Neurol       Date:  1996-04       Impact factor: 0.870

2.  [Diagnostic and therapeutic problems of bilateral carotid-cavernous sinus fistula].

Authors:  Anna Bilbin-Bukowska; Adam Stepień; Krzysztof Brzozowski; Piotr Piasecki; Ewa Skrobowska
Journal:  Pol Merkur Lekarski       Date:  2014-05

Review 3.  [Endovascular management of cavernous sinus dural fistulas].

Authors:  Marco Zenteno; Jorge Santos Franco; Luis Rafael Moscote-Salazar; Angel Lee
Journal:  Bol Asoc Med P R       Date:  2014

4.  Measurement of Choroidal Thickness Following Caffeine Intake in Healthy Subjects.

Authors:  Hasan Altinkaynak; Erdinç Ceylan; Baki Kartal; Sadullah Keleş; Metin Ekinci; Osman Okan Olcaysu
Journal:  Curr Eye Res       Date:  2015-04-10       Impact factor: 2.424

5.  [Spontaneous carotid-cavernous sinus fistula; analysis of 16 cases].

Authors:  T Andoh; T Nakashima; Y Araki; N Sakai; H Yamada; Y Kagawa; T Hirata; Y Tanabe; M Takada
Journal:  No Shinkei Geka       Date:  1991-09

Review 6.  Hemiparesis in carotid cavernous fistulas (CCFs): a case report and review of the literature.

Authors:  Hui-Xiao Wang; Ru-Lin Bai; Cheng-Guang Huang; Yi-Cheng Lu; Guang-Ji Zhang
Journal:  Chin J Traumatol       Date:  2004-10

7.  Quantitative microvascular analysis of retinal venous occlusions by spectral domain optical coherence tomography angiography.

Authors:  Nicole Koulisis; Alice Y Kim; Zhongdi Chu; Anoush Shahidzadeh; Bruce Burkemper; Lisa C Olmos de Koo; Andrew A Moshfeghi; Hossein Ameri; Carmen A Puliafito; Veronica L Isozaki; Ruikang K Wang; Amir H Kashani
Journal:  PLoS One       Date:  2017-04-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.